Statements (50)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:virus
|
| gptkbp:bfsLayer |
7
|
| gptkbp:bfsParent |
gptkb:Paramyxoviridae
|
| gptkbp:affects |
infants
young children |
| gptkbp:caused_by |
respiratory infections
|
| gptkbp:clinical_trial |
fever
nasal congestion irritability reduced appetite |
| gptkbp:complications |
gptkb:healthcare_organization
bronchiolitis |
| gptkbp:family |
gptkb:Paramyxoviridae
|
| gptkbp:genus |
gptkb:Pneumovirus
|
| gptkbp:healthcare |
significant concern
significant in winter months major cause of hospitalization |
| https://www.w3.org/2000/01/rdf-schema#label |
Respiratory syncytial virus
|
| gptkbp:is_protected_by |
hand hygiene
avoidance of sick contacts |
| gptkbp:is_recognized_by |
gptkb:1956
|
| gptkbp:is_vulnerable_to |
no widely available vaccine
|
| gptkbp:lifespan |
higher in high-risk groups
low in healthy children |
| gptkbp:occurs_in |
most common in infants under 1 year
nearly all children infected by age 2 |
| gptkbp:public_awareness |
important for prevention
|
| gptkbp:research |
antiviral therapies
immune response studies ongoing vaccine development |
| gptkbp:risk_factor |
premature birth
chronic lung disease congenital heart disease |
| gptkbp:seasonal_activities |
winter months
annual epidemics |
| gptkbp:social_responsibility |
PCR
global prevalence antigen detection nasal swab |
| gptkbp:symptoms |
cough
fever difficulty breathing wheezing |
| gptkbp:transmission |
airborne droplets
|
| gptkbp:treatment |
supportive care
monoclonal antibodies oxygen therapy nebulized epinephrine |
| gptkbp:type_of |
gptkb:A
B |